Qutboddin Sayed serves as an executive at Pharmsol Group, overseeing strategic initiatives and leadership responsibilities.
| Company | Designation | Period |
|---|---|---|
| Lifepharma FZE | Vice President Operations | Sep 2020 – Jan 2024 |
| Ciplamedica | General Manager Operations | Sep 2014 – Dec 2016 |
| Pharmacare Dubai | Operation Manager | Sep 2006 – Sep 2009 |
| Cipla Goa | Production operations | Oct 2009 – Aug 2014 |
| Medreich meiji pharma | Associated Vice President Technical | May 2018 – Sep 2020 |
| Medreich-Meiji pharma | Senior General Manager-Technical | Dec 2016 – May 2018 |
| Meditab Goa (Unit of Cipla Ltd) | Management Staff | Aug 1998 – Aug 2006 |
| Guf | chemist | Aug 1992 – Aug 1994 |
| PharmSol Europe | Chief Operating Officer | Feb 2024 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Pharmsol Group corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Qutboddin Sayed's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Pharmsol Group's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)